PETCOME
FCV TREATMENT
Targeting feline calicivirus directly
CaliciPro™ provides targeted antiviral support for cats affected by feline calicivirus (FCV) and chronic gingivostomatitis (FCGS). Formulated specifically for feline use with a well-studied active compound.
Active CompoundEIDD-1931
Strength15 mg per tablet
SpeciesFor cats only
- Targets FCV to support management of FCGS
- Well-tolerated and easy to administer
- Designed to reduce viral activity, not just symptoms
FCV-Targeted
Antiviral for FCGS
Targets feline calicivirus (FCV) to help reduce viral activity.
Clinically Studied
EIDD-1931 is a well-studied antiviral compound with a strong safety profile.
Veterinary Formulated
Developed by veterinarians for feline-specific needs.